https://doi.org/10.4081/monaldi.2024.2865
Evaluation of patients’ satisfaction with domiciliary biological treatment in severe asthma: a Portuguese survey
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 20 March 2024
Dear Editor,
According to the Global Initiative for Asthma, severe asthma is defined as uncontrolled asthma, despite therapy adherence with an optimized high dose of inhaled corticosteroid plus long-acting β2-agonist coupled with management of modifiable factors/comorbidities, that worsens when this treatment is decreased...
Downloads
Global Initiative for Asthma. 2023 GINA report, global strategy for asthma management and prevention. 2023. Available from: https://ginasthma.org/2023-gina-main-report/.
Lombardi C, Bagnasco D, Passalacqua G. Biological agents for severe asthma: the evolution of the at-home self-injection approach. Curr Opin Allergy Clin Immunol 2020;20:421-7.
Sitek A, Li JT, Pongdee T. Risks and safety of biologics: a practical guide for allergists. World Allergy Organ J 2023;16:100737.
Blok F, Kocks J, Wouters H, et al. Perceptions on home-administration of biologics in the context of severe asthma: an international qualitative study. J Aller Cl Imm-Pract 2022;10:2312-23.e2.
Ethics Approval
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.